Convergence Financial’s Haleon HLN Stock Holding History

Convergence Financial’s Portfolio HLN Stock Details HLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,958	Closed	-$116K	–	164
2024 Q3	$116K	Sell	10,958 -7,647	-41%	-$73.9K	0.02%	157
2024 Q2	$154K	Buy	+18,605	New	+$155K	0.04%	147

Other funds holding HLN

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Convergence Financial's HLN Position: Q4 2024 in Review

Convergence Financial sold out of Haleon (HLN) in Q4 2024, closing a stake of 10,958 shares — an estimated $116K sold.

Convergence Financial first reported a position in HLN in Q2 2024 and held it in 2 quarters. The position peaked at $154K in Q2 2024. 609 funds tracked by Wall St. Rank hold HLN as of Q4 2024.

Convergence Financial reported no remaining Haleon position as of Q4 2024 after selling out during the quarter.
Convergence Financial sold 10,958 Haleon shares in Q4 2024, an estimated $116K.
Convergence Financial first reported a position in Haleon in Q2 2024 and held it in 2 quarters.
Convergence Financial's Haleon position peaked at $154K in Q2 2024.
609 funds tracked by Wall St. Rank held Haleon as of Q4 2024.

Based on Convergence Financial's 13F filing for Q4 2024, filed 5 Feb 2025.